Dr. Shoshana Shendelman

Dr. Shoshana Shendelman, PhD is a scientist and entrepreneur, founder of several biotech companies, and a pioneer in developing drugs and therapeutics for rare and underserved diseases. Dr. Shendelman received a PhD from Columbia University Vagelos College of Physicians and Surgeons Integrated Program in Cellular, Molecular and Biophysical Studies, where she also completed her Master’s Degrees (both an MA and MSc). Dr. Shendelman’s neurobiological research at Columbia focused on molecular mechanisms driving neurogenerative diseases, and her Doctoral thesis centered around molecular mechanisms of Parkinson’s Disease. She completed her Bachelor’s Degree at Brandeis University, with a BA in biochemistry.